Aelis Farma Publishes Half-Year Financial Results for 2023 and Confirms Its Development Objectives
Acceleration of recruitment in AEF0117 phase 2b trial for the treatment of cannabis addiction and approval obtained in July 2023 by an independent Data Safety Monitoring Board (DSMB) to continue…
Details